Half-year report · Q2

Period2024-12-01 → 2025-05-31
Filed2025-07-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥4.3bn2024-12-01 → 2025-05-31Cons.Net sales
Revenue¥8.9bn2023-12-01 → 2024-11-30Cons.Net sales (5-year summary)
Revenue¥4.2bn2023-12-01 → 2024-05-31Cons.Net sales
Operating income¥199m2024-12-01 → 2025-05-31Cons.Operating income
Operating income¥202m2023-12-01 → 2024-05-31Cons.Operating income
Ordinary income¥183m2024-12-01 → 2025-05-31Cons.Ordinary income
Ordinary income¥390m2023-12-01 → 2024-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥212m2023-12-01 → 2024-05-31Cons.Ordinary income
Profit before tax¥183m2024-12-01 → 2025-05-31Cons.Income before income taxes
Profit before tax¥252m2023-12-01 → 2024-05-31Cons.Income before income taxes
Net income (owners)¥135m2024-12-01 → 2025-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥336m2023-12-01 → 2024-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥193m2023-12-01 → 2024-05-31Cons.Profit loss attributable to owners of parent
Net income¥135m2024-12-01 → 2025-05-31Cons.Profit loss
Net income¥193m2023-12-01 → 2024-05-31Cons.Profit loss
Total assets¥8.8bnat 2025-05-31Cons.Assets
Total assets¥8.5bnat 2024-11-30Cons.Assets
Total assets¥8.0bnat 2024-05-31Cons.Total assets (5-year summary)
Total liabilities¥5.8bnat 2025-05-31Cons.Liabilities
Total liabilities¥5.6bnat 2024-11-30Cons.Liabilities
Net assets / equity¥2.9bnat 2025-05-31Cons.Net assets
Net assets / equity¥2.9bnat 2024-11-30Cons.Net assets
Net assets / equity¥2.7bnat 2024-05-31Cons.Net assets (5-year summary)
Cash and deposits¥1.3bnat 2025-05-31Cons.Cash and deposits
Cash and deposits¥745mat 2024-11-30Cons.Cash and deposits
Cash & equivalents¥1.3bnat 2025-05-31Cons.Cash and cash equivalents
Cash & equivalents¥745mat 2024-11-30Cons.Cash and cash equivalents
Cash & equivalents¥947mat 2024-05-31Cons.Cash and cash equivalents
Cash & equivalents¥1.0bnat 2023-11-30vCons.Cash and cash equivalents
Operating cash flow¥566m2024-12-01 → 2025-05-31Cons.Net cash provided by used in operating activities
Operating cash flow¥143m2023-12-01 → 2024-11-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥90m2023-12-01 → 2024-05-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥216m2024-12-01 → 2025-05-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥305m2023-12-01 → 2024-11-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥96m2023-12-01 → 2024-05-31Cons.Net cash provided by used in investment activities
Financing cash flow¥187m2024-12-01 → 2025-05-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥139m2023-12-01 → 2024-11-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥101m2023-12-01 → 2024-05-31Cons.Net cash provided by used in financing activities
EPS (basic)¥110.522024-12-01 → 2025-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥276.222023-12-01 → 2024-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥158.382023-12-01 → 2024-05-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio33.5%at 2025-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio33.8%at 2024-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio34.2%at 2024-05-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue2024-12-01 → 2025-05-31¥4.3bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2024-12-01 → 2025-05-31¥4.3bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2024-12-01 → 2025-05-31¥184m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue2024-12-01 → 2025-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue external2024-12-01 → 2025-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentsegment profit2024-12-01 → 2025-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2024-12-01 → 2025-05-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-12-01 → 2025-05-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-12-01 → 2025-05-31¥199m
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue2023-12-01 → 2024-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2023-12-01 → 2024-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2023-12-01 → 2024-05-31¥187m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue2023-12-01 → 2024-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue external2023-12-01 → 2024-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentsegment profit2023-12-01 → 2024-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2023-12-01 → 2024-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-12-01 → 2024-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-12-01 → 2024-05-31¥202m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 484
ItemContextValueUnit
Non operating incomePrior1YTDDuration19275000JPY
Non operating incomeCurrentYTDDuration7890000JPY
Interest expenses noePrior1YTDDuration9474000JPY
Interest expenses noeCurrentYTDDuration17025000JPY
Foreign exchange losses noePrior1YTDDuration-JPY
Foreign exchange losses noeCurrentYTDDuration6408000JPY
Other noePrior1YTDDuration333000JPY
Other noeCurrentYTDDuration69000JPY
Non operating expensesPrior1YTDDuration9808000JPY
Non operating expensesCurrentYTDDuration23502000JPY
Ordinary incomePrior1YTDDuration211885000JPY
Ordinary incomeCurrentYTDDuration183335000JPY
Gain on sales of investment securities eiPrior1YTDDuration42660000JPY
Gain on sales of investment securities eiCurrentYTDDuration-JPY
Extraordinary incomePrior1YTDDuration42660000JPY
Extraordinary incomeCurrentYTDDuration-JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration2146000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration233000JPY
Extraordinary lossPrior1YTDDuration2146000JPY
Extraordinary lossCurrentYTDDuration233000JPY
Income before income taxesPrior1YTDDuration252399000JPY
Income before income taxesCurrentYTDDuration183101000JPY
Income taxes currentPrior1YTDDuration40715000JPY
Income taxes currentCurrentYTDDuration41018000JPY
Income taxes deferredPrior1YTDDuration18857000JPY
Income taxes deferredCurrentYTDDuration7535000JPY
Income taxesPrior1YTDDuration59572000JPY
Income taxesCurrentYTDDuration48554000JPY
Profit lossPrior1YTDDuration192827000JPY
Profit lossCurrentYTDDuration134547000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-JPY
Profit loss attributable to owners of parentPrior1YTDDuration192827000JPY
Profit loss attributable to owners of parentCurrentYTDDuration134547000JPY
Profit lossPrior1YTDDuration192827000JPY
Profit lossCurrentYTDDuration134547000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-30909000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration2408000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration10161000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration-7985000JPY
Other comprehensive incomePrior1YTDDuration-20748000JPY
Other comprehensive incomeCurrentYTDDuration-5577000JPY
Comprehensive incomePrior1YTDDuration172078000JPY
Comprehensive incomeCurrentYTDDuration128969000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration172078000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration128969000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-JPY
Income before income taxesPrior1YTDDuration252399000JPY
Income before income taxesCurrentYTDDuration183101000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-11-30pass rounding
balance sheet identityconsolidated 2025-05-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-11-30pass
statement vs summary · net assetsconsolidated 2025-05-31pass
statement vs summary · net income attributable to parentconsolidated 2023-12-01/2024-05-31pass
statement vs summary · net income attributable to parentconsolidated 2024-12-01/2025-05-31pass
statement vs summary · operating cash flowconsolidated 2023-12-01/2024-05-31pass
statement vs summary · operating cash flowconsolidated 2024-12-01/2025-05-31pass
statement vs summary · revenueconsolidated 2023-12-01/2024-05-31pass
statement vs summary · revenueconsolidated 2024-12-01/2025-05-31pass
statement vs summary · total assetsconsolidated 2024-11-30pass
statement vs summary · total assetsconsolidated 2025-05-31pass